

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.63753017 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.63753017 |
| 3 | fatty acid elongation (GO:0030497) | 7.04951487 |
| 4 | cholesterol biosynthetic process (GO:0006695) | 5.26166709 |
| 5 | ensheathment of neurons (GO:0007272) | 4.96299201 |
| 6 | axon ensheathment (GO:0008366) | 4.96299201 |
| 7 | amyloid precursor protein metabolic process (GO:0042982) | 4.92063761 |
| 8 | myelination (GO:0042552) | 4.89546004 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.85451211 |
| 10 | response to peptidoglycan (GO:0032494) | 4.73826911 |
| 11 | amyloid precursor protein catabolic process (GO:0042987) | 4.68969140 |
| 12 | sterol biosynthetic process (GO:0016126) | 4.67165964 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.52402389 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.47907561 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.41569546 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.41569546 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.41569546 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.41569546 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.41569546 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 4.41569546 |
| 21 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.40594631 |
| 22 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.34009987 |
| 23 | myelin maintenance (GO:0043217) | 4.28821057 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 4.16476744 |
| 25 | isoprenoid biosynthetic process (GO:0008299) | 4.11734195 |
| 26 | creatine metabolic process (GO:0006600) | 4.08692701 |
| 27 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.05282665 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 3.98088882 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 3.90135261 |
| 30 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.88759798 |
| 31 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.77199118 |
| 32 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.76805943 |
| 33 | detection of other organism (GO:0098543) | 3.75969726 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.74532451 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68661557 |
| 36 | detection of bacterium (GO:0016045) | 3.66811689 |
| 37 | response to lipoprotein particle (GO:0055094) | 3.64240950 |
| 38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.63634063 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.62736647 |
| 40 | positive regulation of B cell differentiation (GO:0045579) | 3.59408028 |
| 41 | B cell mediated immunity (GO:0019724) | 3.53704062 |
| 42 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.51097229 |
| 43 | negative regulation of cell killing (GO:0031342) | 3.51064377 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.51064377 |
| 45 | respiratory burst (GO:0045730) | 3.47642928 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 3.43440186 |
| 47 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40716676 |
| 48 | protein neddylation (GO:0045116) | 3.40690628 |
| 49 | adhesion of symbiont to host cell (GO:0044650) | 3.40473820 |
| 50 | virion attachment to host cell (GO:0019062) | 3.40473820 |
| 51 | regulation of collateral sprouting (GO:0048670) | 3.40299624 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.37122356 |
| 53 | acyl-CoA biosynthetic process (GO:0071616) | 3.36515091 |
| 54 | thioester biosynthetic process (GO:0035384) | 3.36515091 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36443864 |
| 56 | regulation of leukocyte degranulation (GO:0043300) | 3.35754262 |
| 57 | regulation of superoxide anion generation (GO:0032928) | 3.30610545 |
| 58 | GPI anchor biosynthetic process (GO:0006506) | 3.28675754 |
| 59 | response to host immune response (GO:0052572) | 3.24019319 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.24019319 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.23344883 |
| 62 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.20924317 |
| 63 | cellular extravasation (GO:0045123) | 3.18313595 |
| 64 | leukocyte aggregation (GO:0070486) | 3.16939931 |
| 65 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.16162824 |
| 66 | detection of external biotic stimulus (GO:0098581) | 3.16159689 |
| 67 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14392487 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 3.12769079 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.08087454 |
| 70 | response to methylmercury (GO:0051597) | 3.07656337 |
| 71 | regulation of lipoprotein metabolic process (GO:0050746) | 3.04332603 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04125688 |
| 73 | very long-chain fatty acid metabolic process (GO:0000038) | 3.01007030 |
| 74 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00975766 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 3.00654254 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.00654254 |
| 77 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.98923313 |
| 78 | substantia nigra development (GO:0021762) | 2.98726229 |
| 79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.92873627 |
| 80 | membrane raft organization (GO:0031579) | 2.92615634 |
| 81 | glycosylceramide metabolic process (GO:0006677) | 2.92463215 |
| 82 | GPI anchor metabolic process (GO:0006505) | 2.89927875 |
| 83 | regulation of gamma-delta T cell activation (GO:0046643) | 2.87935454 |
| 84 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.87472839 |
| 85 | response to host (GO:0075136) | 2.87472839 |
| 86 | response to host defenses (GO:0052200) | 2.87472839 |
| 87 | response to redox state (GO:0051775) | 2.87243723 |
| 88 | glycerophospholipid catabolic process (GO:0046475) | 2.86872611 |
| 89 | signal peptide processing (GO:0006465) | 2.83326151 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81135556 |
| 91 | aldehyde catabolic process (GO:0046185) | 2.80966853 |
| 92 | adhesion of symbiont to host (GO:0044406) | 2.80547506 |
| 93 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.80530623 |
| 94 | ATP synthesis coupled proton transport (GO:0015986) | 2.80530623 |
| 95 | positive regulation of pseudopodium assembly (GO:0031274) | 2.80461857 |
| 96 | detection of molecule of bacterial origin (GO:0032490) | 2.79530694 |
| 97 | neutrophil activation (GO:0042119) | 2.79274680 |
| 98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.79133642 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78887016 |
| 100 | positive regulation of antigen processing and presentation (GO:0002579) | 2.78171592 |
| 101 | import into cell (GO:0098657) | 2.78026717 |
| 102 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.76581667 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.74544260 |
| 104 | pinocytosis (GO:0006907) | 2.74450519 |
| 105 | regulation of B cell apoptotic process (GO:0002902) | 2.74345996 |
| 106 | positive regulation of interleukin-17 production (GO:0032740) | 2.74321391 |
| 107 | detection of biotic stimulus (GO:0009595) | 2.73970559 |
| 108 | nucleotide transmembrane transport (GO:1901679) | 2.73167298 |
| 109 | microglial cell activation (GO:0001774) | 2.72888921 |
| 110 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.72815917 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 2.71753240 |
| 112 | regulation of regulated secretory pathway (GO:1903305) | 2.71354179 |
| 113 | negative regulation of acute inflammatory response (GO:0002674) | 2.70839220 |
| 114 | negative regulation of chemokine production (GO:0032682) | 2.69931721 |
| 115 | negative regulation of phagocytosis (GO:0050765) | 2.69707947 |
| 116 | response to protozoan (GO:0001562) | 2.68419635 |
| 117 | defense response to protozoan (GO:0042832) | 2.68147205 |
| 118 | macrophage activation (GO:0042116) | 2.67485798 |
| 119 | amino sugar catabolic process (GO:0046348) | 2.67464648 |
| 120 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.66899589 |
| 121 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66097333 |
| 122 | regulation of B cell differentiation (GO:0045577) | 2.65217123 |
| 123 | positive regulation of actin filament depolymerization (GO:0030836) | 2.65036728 |
| 124 | oligodendrocyte differentiation (GO:0048709) | 2.64603052 |
| 125 | triglyceride biosynthetic process (GO:0019432) | 2.64583786 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.62179729 |
| 127 | heme transport (GO:0015886) | 2.61766543 |
| 128 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.61694832 |
| 129 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.61099920 |
| 130 | regulation of metalloenzyme activity (GO:0048552) | 2.61056725 |
| 131 | membrane protein ectodomain proteolysis (GO:0006509) | 2.60401611 |
| 132 | astrocyte development (GO:0014002) | 2.59063845 |
| 133 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.58094149 |
| 134 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.57884165 |
| 135 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.57384284 |
| 136 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.57313049 |
| 137 | response to interferon-beta (GO:0035456) | 2.55536339 |
| 138 | negative regulation of innate immune response (GO:0045824) | 2.54887424 |
| 139 | granulocyte activation (GO:0036230) | 2.54386013 |
| 140 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.54037477 |
| 141 | low-density lipoprotein particle clearance (GO:0034383) | 2.53991093 |
| 142 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.53719357 |
| 143 | peptidyl-cysteine modification (GO:0018198) | 2.53679941 |
| 144 | mature B cell differentiation involved in immune response (GO:0002313) | 2.53454452 |
| 145 | mannosylation (GO:0097502) | 2.53066275 |
| 146 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.52740152 |
| 147 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.52715536 |
| 148 | nuclear envelope reassembly (GO:0031468) | 2.52424684 |
| 149 | mitotic nuclear envelope reassembly (GO:0007084) | 2.52424684 |
| 150 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52057927 |
| 151 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51668960 |
| 152 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.50989454 |
| 153 | acyl-CoA metabolic process (GO:0006637) | 2.50513251 |
| 154 | thioester metabolic process (GO:0035383) | 2.50513251 |
| 155 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50321069 |
| 156 | purine nucleotide salvage (GO:0032261) | 2.49711732 |
| 157 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.49551673 |
| 158 | glutathione derivative biosynthetic process (GO:1901687) | 2.47728164 |
| 159 | glutathione derivative metabolic process (GO:1901685) | 2.47728164 |
| 160 | tissue regeneration (GO:0042246) | 2.47562828 |
| 161 | heme metabolic process (GO:0042168) | 2.47479079 |
| 162 | L-methionine salvage (GO:0071267) | 2.47235367 |
| 163 | L-methionine biosynthetic process (GO:0071265) | 2.47235367 |
| 164 | amino acid salvage (GO:0043102) | 2.47235367 |
| 165 | alcohol biosynthetic process (GO:0046165) | 2.47052085 |
| 166 | positive regulation of leukocyte degranulation (GO:0043302) | 2.47045921 |
| 167 | negative regulation of B cell apoptotic process (GO:0002903) | 2.46765841 |
| 168 | heme biosynthetic process (GO:0006783) | 2.45956993 |
| 169 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.45162193 |
| 170 | phagosome maturation (GO:0090382) | 2.44896383 |
| 171 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.44624226 |
| 172 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.44618494 |
| 173 | myeloid cell homeostasis (GO:0002262) | 2.43812035 |
| 174 | L-serine metabolic process (GO:0006563) | 2.43727013 |
| 175 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.43603481 |
| 176 | respiratory electron transport chain (GO:0022904) | 2.42657516 |
| 177 | acylglycerol biosynthetic process (GO:0046463) | 2.42482033 |
| 178 | neutral lipid biosynthetic process (GO:0046460) | 2.42482033 |
| 179 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.41742578 |
| 180 | B cell receptor signaling pathway (GO:0050853) | 2.41637097 |
| 181 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.41147424 |
| 182 | response to muramyl dipeptide (GO:0032495) | 2.41051787 |
| 183 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.40952018 |
| 184 | ethanol metabolic process (GO:0006067) | 2.40730619 |
| 185 | regulation of pseudopodium assembly (GO:0031272) | 2.40417686 |
| 186 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.40192163 |
| 187 | superoxide anion generation (GO:0042554) | 2.39690691 |
| 188 | negative regulation of interleukin-6 production (GO:0032715) | 2.39159744 |
| 189 | leukocyte degranulation (GO:0043299) | 2.38979953 |
| 190 | lipoxygenase pathway (GO:0019372) | 2.38597184 |
| 191 | fatty acid biosynthetic process (GO:0006633) | 2.38461579 |
| 192 | response to thyroid hormone (GO:0097066) | 2.37629797 |
| 193 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37280039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.30955550 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.67823760 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.22106955 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.19401653 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.95182530 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.92176587 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.75698952 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.73153077 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.69477865 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.63248515 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.36136876 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33928664 |
| 13 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.32464190 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.30465790 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.24331197 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.24168494 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18198720 |
| 18 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16669983 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08638913 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.00722690 |
| 21 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.96588476 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94572471 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.93448165 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.88544438 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82945653 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.82448936 |
| 27 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.82178671 |
| 28 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81264129 |
| 29 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.80656044 |
| 30 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80574022 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79616770 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78838141 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.73764356 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68121335 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65872521 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65740796 |
| 37 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.64329782 |
| 38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60334444 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58213513 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.57578207 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56565981 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54432834 |
| 43 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.52763062 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51973953 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50627434 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49936345 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48812382 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47833768 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47605957 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47410096 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45751752 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41334408 |
| 53 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39440783 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.38151719 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35991041 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35790188 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35703523 |
| 58 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34188585 |
| 59 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33887644 |
| 60 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33842524 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.33666371 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33121655 |
| 63 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32683379 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29018884 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27958906 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27506614 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26553231 |
| 68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.26063074 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.25867023 |
| 70 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25104628 |
| 71 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24826877 |
| 72 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24721747 |
| 73 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24569892 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24220614 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22731995 |
| 76 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21787490 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21761541 |
| 78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21742919 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20288107 |
| 80 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18943076 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15881815 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15482835 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14173625 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13633434 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13494278 |
| 86 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10611544 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10185046 |
| 88 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09380131 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08887554 |
| 90 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08051859 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06106383 |
| 92 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05953538 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04605401 |
| 94 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04229256 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04134729 |
| 96 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02670069 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02424678 |
| 98 | * P68_20966046_ChIP-Seq_HELA_Human | 1.02234658 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01783051 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00322608 |
| 101 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00102221 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99635901 |
| 103 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99624536 |
| 104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98754495 |
| 105 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98572319 |
| 106 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98130762 |
| 107 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97952774 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97925016 |
| 109 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.97419735 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97257224 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96887208 |
| 112 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96852323 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96759369 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95854903 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95818239 |
| 116 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95506914 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95306049 |
| 118 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94404293 |
| 119 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.92599588 |
| 120 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.90767474 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90289038 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90217131 |
| 123 | MYB_26560356_Chip-Seq_TH2_Human | 0.89884172 |
| 124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89788319 |
| 125 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86738567 |
| 126 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.86491198 |
| 127 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.86326854 |
| 128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86082839 |
| 129 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85851325 |
| 130 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.84774177 |
| 131 | MAF_26560356_Chip-Seq_TH2_Human | 0.82787628 |
| 132 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82269085 |
| 133 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81726251 |
| 134 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.81656755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.04686830 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.71440125 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.37438100 |
| 4 | MP0003690_abnormal_glial_cell | 2.94701552 |
| 5 | MP0003656_abnormal_erythrocyte_physiolo | 2.66751271 |
| 6 | MP0009278_abnormal_bone_marrow | 2.64942155 |
| 7 | MP0003186_abnormal_redox_activity | 2.61300890 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 2.58086457 |
| 9 | MP0001545_abnormal_hematopoietic_system | 2.58086457 |
| 10 | MP0009785_altered_susceptibility_to | 2.53376649 |
| 11 | MP0009840_abnormal_foam_cell | 2.39115371 |
| 12 | MP0006082_CNS_inflammation | 2.37714643 |
| 13 | MP0005451_abnormal_body_composition | 2.37278966 |
| 14 | MP0002419_abnormal_innate_immunity | 2.34210563 |
| 15 | MP0004147_increased_porphyrin_level | 2.31341560 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.22203982 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.20964116 |
| 18 | MP0003436_decreased_susceptibility_to | 2.18380723 |
| 19 | MP0005025_abnormal_response_to | 2.17054485 |
| 20 | MP0003724_increased_susceptibility_to | 2.13665621 |
| 21 | MP0008260_abnormal_autophagy | 2.12092185 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.04740085 |
| 23 | * MP0003806_abnormal_nucleotide_metabolis | 1.91034102 |
| 24 | MP0003329_amyloid_beta_deposits | 1.86150583 |
| 25 | MP0001529_abnormal_vocalization | 1.85018269 |
| 26 | MP0009764_decreased_sensitivity_to | 1.77132192 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.74668107 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.69758630 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.67409989 |
| 30 | MP0000604_amyloidosis | 1.67113730 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.63707186 |
| 32 | MP0003634_abnormal_glial_cell | 1.62356234 |
| 33 | MP0002723_abnormal_immune_serum | 1.56282832 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.56088485 |
| 35 | MP0001905_abnormal_dopamine_level | 1.55865175 |
| 36 | MP0003136_yellow_coat_color | 1.55384659 |
| 37 | MP0000858_altered_metastatic_potential | 1.55243296 |
| 38 | MP0001661_extended_life_span | 1.54160690 |
| 39 | MP0003303_peritoneal_inflammation | 1.54077125 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.53840752 |
| 41 | MP0000685_abnormal_immune_system | 1.53162311 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.52386491 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.48417410 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.48392812 |
| 45 | MP0005387_immune_system_phenotype | 1.47618537 |
| 46 | MP0001790_abnormal_immune_system | 1.47618537 |
| 47 | MP0001819_abnormal_immune_cell | 1.47588455 |
| 48 | MP0002722_abnormal_immune_system | 1.46867666 |
| 49 | MP0004742_abnormal_vestibular_system | 1.44976035 |
| 50 | MP0005671_abnormal_response_to | 1.44498595 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.43819279 |
| 52 | MP0000343_altered_response_to | 1.42501794 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.41571081 |
| 54 | MP0001851_eye_inflammation | 1.40650078 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.36160541 |
| 56 | MP0004043_abnormal_pH_regulation | 1.33502132 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.33460768 |
| 58 | MP0000383_abnormal_hair_follicle | 1.30803917 |
| 59 | MP0001800_abnormal_humoral_immune | 1.30588828 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.30552866 |
| 61 | MP0001485_abnormal_pinna_reflex | 1.25677350 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.25225822 |
| 63 | MP0003075_altered_response_to | 1.23939338 |
| 64 | MP0004381_abnormal_hair_follicle | 1.22520095 |
| 65 | MP0005171_absent_coat_pigmentation | 1.20768165 |
| 66 | MP0005408_hypopigmentation | 1.18860983 |
| 67 | MP0002405_respiratory_system_inflammati | 1.17132921 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16480772 |
| 69 | MP0002933_joint_inflammation | 1.16475910 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.16375559 |
| 71 | MP0008469_abnormal_protein_level | 1.15902123 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 1.14922601 |
| 73 | MP0003828_pulmonary_edema | 1.14918377 |
| 74 | MP0008004_abnormal_stomach_pH | 1.10737445 |
| 75 | MP0000015_abnormal_ear_pigmentation | 1.09392609 |
| 76 | MP0003632_abnormal_nervous_system | 1.09115883 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.07171223 |
| 78 | MP0000462_abnormal_digestive_system | 1.06226745 |
| 79 | MP0000716_abnormal_immune_system | 1.05693736 |
| 80 | MP0003011_delayed_dark_adaptation | 1.03183827 |
| 81 | MP0005310_abnormal_salivary_gland | 1.03150460 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.03077687 |
| 83 | MP0004142_abnormal_muscle_tone | 1.02698586 |
| 84 | MP0003195_calcinosis | 1.01124228 |
| 85 | MP0005166_decreased_susceptibility_to | 1.00926953 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 1.00613836 |
| 87 | MP0010155_abnormal_intestine_physiology | 0.99782099 |
| 88 | MP0005164_abnormal_response_to | 0.98843139 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.98294392 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.97757675 |
| 91 | MP0002229_neurodegeneration | 0.97586967 |
| 92 | MP0004510_myositis | 0.96078873 |
| 93 | MP0004947_skin_inflammation | 0.95927951 |
| 94 | MP0005381_digestive/alimentary_phenotyp | 0.95865593 |
| 95 | MP0001727_abnormal_embryo_implantation | 0.93550330 |
| 96 | MP0008873_increased_physiological_sensi | 0.93295605 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.92878209 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.92876744 |
| 99 | MP0002429_abnormal_blood_cell | 0.92242209 |
| 100 | MP0004885_abnormal_endolymph | 0.91483847 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.91419433 |
| 102 | MP0009643_abnormal_urine_homeostasis | 0.90875775 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.90564587 |
| 104 | MP0005083_abnormal_biliary_tract | 0.90467679 |
| 105 | MP0001853_heart_inflammation | 0.89455232 |
| 106 | MP0001663_abnormal_digestive_system | 0.88827666 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.87163894 |
| 108 | MP0009763_increased_sensitivity_to | 0.86614842 |
| 109 | MP0001666_abnormal_nutrient_absorption | 0.85635845 |
| 110 | MP0005165_increased_susceptibility_to | 0.85516784 |
| 111 | MP0002132_abnormal_respiratory_system | 0.85312549 |
| 112 | MP0001873_stomach_inflammation | 0.85246623 |
| 113 | MP0003448_altered_tumor_morphology | 0.84537081 |
| 114 | MP0004134_abnormal_chest_morphology | 0.84392160 |
| 115 | MP0005409_darkened_coat_color | 0.83776417 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.81456891 |
| 117 | MP0003866_abnormal_defecation | 0.81371783 |
| 118 | MP0002398_abnormal_bone_marrow | 0.80494174 |
| 119 | MP0005390_skeleton_phenotype | 0.79839081 |
| 120 | MP0004883_abnormal_blood_vessel | 0.79679158 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.77528419 |
| 122 | MP0000490_abnormal_crypts_of | 0.76445382 |
| 123 | MP0001764_abnormal_homeostasis | 0.74196402 |
| 124 | MP0005075_abnormal_melanosome_morpholog | 0.72736231 |
| 125 | MP0000372_irregular_coat_pigmentation | 0.72683586 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.72658407 |
| 127 | MP0005332_abnormal_amino_acid | 0.70962023 |
| 128 | MP0002295_abnormal_pulmonary_circulatio | 0.70729356 |
| 129 | MP0000647_abnormal_sebaceous_gland | 0.70303476 |
| 130 | MP0000609_abnormal_liver_physiology | 0.70035161 |
| 131 | MP0000313_abnormal_cell_death | 0.69813727 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.69539910 |
| 133 | MP0008874_decreased_physiological_sensi | 0.65665753 |
| 134 | MP0003795_abnormal_bone_structure | 0.65359363 |
| 135 | MP0002254_reproductive_system_inflammat | 0.64566840 |
| 136 | MP0008007_abnormal_cellular_replicative | 0.59584225 |
| 137 | MP0005084_abnormal_gallbladder_morpholo | 0.59033098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolysis (HP:0004366) | 4.57240895 |
| 2 | Increased serum pyruvate (HP:0003542) | 4.57240895 |
| 3 | Parakeratosis (HP:0001036) | 4.50337685 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.47530246 |
| 5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.47530246 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.15647309 |
| 7 | Cerebral hypomyelination (HP:0006808) | 4.02117158 |
| 8 | Myositis (HP:0100614) | 4.00478018 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.95434700 |
| 10 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.95370583 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.81118627 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.77009656 |
| 13 | Prolonged bleeding time (HP:0003010) | 3.59555193 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.55765230 |
| 15 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.50775107 |
| 16 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.45859488 |
| 17 | Orchitis (HP:0100796) | 3.35790513 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.33396860 |
| 19 | * Hepatosplenomegaly (HP:0001433) | 3.30957218 |
| 20 | Sensory axonal neuropathy (HP:0003390) | 3.28111599 |
| 21 | Axonal loss (HP:0003447) | 3.20108774 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.15839697 |
| 23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04222337 |
| 24 | Peripheral hypomyelination (HP:0007182) | 3.01433559 |
| 25 | Meningitis (HP:0001287) | 2.97967508 |
| 26 | Leukodystrophy (HP:0002415) | 2.97373814 |
| 27 | Epistaxis (HP:0000421) | 2.97267720 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.96494596 |
| 29 | Spastic paraparesis (HP:0002313) | 2.91470874 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.88181432 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.84314805 |
| 32 | Optic neuritis (HP:0100653) | 2.84314805 |
| 33 | Hepatocellular necrosis (HP:0001404) | 2.83849727 |
| 34 | Cellulitis (HP:0100658) | 2.82715111 |
| 35 | Hypertensive crisis (HP:0100735) | 2.79036529 |
| 36 | Stridor (HP:0010307) | 2.78561188 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.76937049 |
| 38 | Hepatic necrosis (HP:0002605) | 2.71683086 |
| 39 | Abnormality of the corticospinal tract (HP:0002492) | 2.69045734 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.65485676 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 2.65445123 |
| 42 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.65053295 |
| 43 | Cerebral inclusion bodies (HP:0100314) | 2.62451181 |
| 44 | Mitochondrial inheritance (HP:0001427) | 2.62199981 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.59664490 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56411027 |
| 47 | Recurrent viral infections (HP:0004429) | 2.55665574 |
| 48 | Encephalitis (HP:0002383) | 2.55422550 |
| 49 | Recurrent skin infections (HP:0001581) | 2.55346213 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.54915434 |
| 51 | Cerebral hemorrhage (HP:0001342) | 2.54299021 |
| 52 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.53358303 |
| 53 | Increased IgM level (HP:0003496) | 2.52864861 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.48091988 |
| 55 | Thrombocytosis (HP:0001894) | 2.46308911 |
| 56 | Acute encephalopathy (HP:0006846) | 2.46278125 |
| 57 | Gingivitis (HP:0000230) | 2.46069383 |
| 58 | Loss of speech (HP:0002371) | 2.42787513 |
| 59 | Increased IgE level (HP:0003212) | 2.42034238 |
| 60 | Obstructive lung disease (HP:0006536) | 2.41575886 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41575886 |
| 62 | Onion bulb formation (HP:0003383) | 2.39857766 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.39678782 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38754214 |
| 65 | CNS hypomyelination (HP:0003429) | 2.36155774 |
| 66 | Stomatitis (HP:0010280) | 2.35961889 |
| 67 | Premature skin wrinkling (HP:0100678) | 2.35609426 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34436109 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34436109 |
| 70 | Autoimmune thrombocytopenia (HP:0001973) | 2.33367437 |
| 71 | Petechiae (HP:0000967) | 2.31624089 |
| 72 | Gingival bleeding (HP:0000225) | 2.31523600 |
| 73 | Increased serum ferritin (HP:0003281) | 2.31418247 |
| 74 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.31074121 |
| 75 | Increased hepatocellular lipid droplets (HP:0006565) | 2.30136772 |
| 76 | Purpura (HP:0000979) | 2.29256378 |
| 77 | Prolonged neonatal jaundice (HP:0006579) | 2.27650303 |
| 78 | Abnormal auditory evoked potentials (HP:0006958) | 2.27101143 |
| 79 | Vasculitis (HP:0002633) | 2.26818189 |
| 80 | Lipid accumulation in hepatocytes (HP:0006561) | 2.24958958 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.24512586 |
| 82 | Ileus (HP:0002595) | 2.24237129 |
| 83 | Chest pain (HP:0100749) | 2.23433209 |
| 84 | Granulocytopenia (HP:0001913) | 2.20410963 |
| 85 | Anorexia (HP:0002039) | 2.19139983 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18526415 |
| 87 | Respiratory failure (HP:0002878) | 2.18340457 |
| 88 | Polycythemia (HP:0001901) | 2.18119325 |
| 89 | Hypochromic microcytic anemia (HP:0004840) | 2.17723065 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.17452132 |
| 91 | Increased CSF lactate (HP:0002490) | 2.16853295 |
| 92 | Paralysis (HP:0003470) | 2.15730494 |
| 93 | Abnormal platelet volume (HP:0011876) | 2.14750640 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.13194157 |
| 95 | Cholecystitis (HP:0001082) | 2.13194157 |
| 96 | Chronic otitis media (HP:0000389) | 2.12721790 |
| 97 | Microcytic anemia (HP:0001935) | 2.12239645 |
| 98 | Postnatal microcephaly (HP:0005484) | 2.10493669 |
| 99 | Slow saccadic eye movements (HP:0000514) | 2.09818944 |
| 100 | Hypochromic anemia (HP:0001931) | 2.07875658 |
| 101 | Pustule (HP:0200039) | 2.07625041 |
| 102 | Keratoconjunctivitis sicca (HP:0001097) | 2.06795528 |
| 103 | Osteomyelitis (HP:0002754) | 2.06351452 |
| 104 | Pulmonary infiltrates (HP:0002113) | 2.05616122 |
| 105 | Dysostosis multiplex (HP:0000943) | 2.05612826 |
| 106 | Gastrointestinal inflammation (HP:0004386) | 2.05512956 |
| 107 | Autoamputation (HP:0001218) | 2.04989528 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 2.04131403 |
| 109 | Ragged-red muscle fibers (HP:0003200) | 2.03763506 |
| 110 | Impaired platelet aggregation (HP:0003540) | 2.03200701 |
| 111 | Abnormal platelet function (HP:0011869) | 2.03200701 |
| 112 | Arterial thrombosis (HP:0004420) | 2.02796969 |
| 113 | Leukocytosis (HP:0001974) | 2.00611775 |
| 114 | Disinhibition (HP:0000734) | 2.00257143 |
| 115 | Increased muscle lipid content (HP:0009058) | 1.99355417 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98859523 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98859523 |
| 118 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98859523 |
| 119 | Erythroderma (HP:0001019) | 1.97155747 |
| 120 | Paraparesis (HP:0002385) | 1.97091487 |
| 121 | Progressive macrocephaly (HP:0004481) | 1.96413835 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95375545 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95375545 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95375545 |
| 125 | Inflammation of the large intestine (HP:0002037) | 1.95301225 |
| 126 | Supranuclear gaze palsy (HP:0000605) | 1.93567430 |
| 127 | Hemoptysis (HP:0002105) | 1.92633410 |
| 128 | Patchy hypopigmentation of hair (HP:0011365) | 1.92376885 |
| 129 | Microvesicular hepatic steatosis (HP:0001414) | 1.90079217 |
| 130 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.89871899 |
| 131 | Agammaglobulinemia (HP:0004432) | 1.89835297 |
| 132 | Exertional dyspnea (HP:0002875) | 1.88804790 |
| 133 | Morphological abnormality of the inner ear (HP:0011390) | 1.87921097 |
| 134 | Abnormality of T cell physiology (HP:0011840) | 1.87780171 |
| 135 | Splenomegaly (HP:0001744) | 1.87596402 |
| 136 | Methylmalonic acidemia (HP:0002912) | 1.87572347 |
| 137 | Abnormality of iron homeostasis (HP:0011031) | 1.87547930 |
| 138 | Abnormality of T cells (HP:0002843) | 1.86937534 |
| 139 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86021441 |
| 140 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85883971 |
| 141 | Skin rash (HP:0000988) | 1.84087747 |
| 142 | Akinesia (HP:0002304) | 1.83676348 |
| 143 | Autoimmune hemolytic anemia (HP:0001890) | 1.83621474 |
| 144 | Urticaria (HP:0001025) | 1.83357828 |
| 145 | Keratoconjunctivitis (HP:0001096) | 1.83218935 |
| 146 | Amaurosis fugax (HP:0100576) | 1.82546751 |
| 147 | Skin ulcer (HP:0200042) | 1.82174185 |
| 148 | Myocardial infarction (HP:0001658) | 1.81991750 |
| 149 | Nausea (HP:0002018) | 1.81741396 |
| 150 | Acute hepatic failure (HP:0006554) | 1.80977947 |
| 151 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.80937546 |
| 152 | Upper motor neuron abnormality (HP:0002127) | 1.80549460 |
| 153 | Amyloidosis (HP:0011034) | 1.77567507 |
| 154 | Abnormality of renal resorption (HP:0011038) | 1.77489685 |
| 155 | Hypoplastic pelvis (HP:0008839) | 1.76514466 |
| 156 | Hypomagnesemia (HP:0002917) | 1.76402249 |
| 157 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75540374 |
| 158 | Metabolic alkalosis (HP:0200114) | 1.75351680 |
| 159 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.75319414 |
| 160 | Poor head control (HP:0002421) | 1.75067066 |
| 161 | Peripheral demyelination (HP:0011096) | 1.74666201 |
| 162 | Abnormal number of erythroid precursors (HP:0012131) | 1.74595338 |
| 163 | Methylmalonic aciduria (HP:0012120) | 1.74191694 |
| 164 | Increased serum lactate (HP:0002151) | 1.73551542 |
| 165 | Episodic fever (HP:0001954) | 1.72901729 |
| 166 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.71967467 |
| 167 | Dicarboxylic aciduria (HP:0003215) | 1.71967467 |
| 168 | Duplicated collecting system (HP:0000081) | 1.71622541 |
| 169 | Gastrointestinal stroma tumor (HP:0100723) | 1.70954269 |
| 170 | Hypokalemic alkalosis (HP:0001949) | 1.70833874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.04712801 |
| 2 | PBK | 4.28295501 |
| 3 | EPHB1 | 4.19202668 |
| 4 | RIPK4 | 4.09696511 |
| 5 | OXSR1 | 3.48747829 |
| 6 | TESK2 | 3.40612706 |
| 7 | MST4 | 3.17465763 |
| 8 | MAP3K11 | 2.95971229 |
| 9 | MAP2K3 | 2.88302531 |
| 10 | VRK2 | 2.26297695 |
| 11 | MAPKAPK5 | 2.21786668 |
| 12 | MET | 2.17989733 |
| 13 | BLK | 2.13364743 |
| 14 | LIMK1 | 2.12508581 |
| 15 | CLK1 | 2.10899479 |
| 16 | TAOK2 | 2.02656433 |
| 17 | BCR | 1.99865239 |
| 18 | IRAK4 | 1.96882842 |
| 19 | MAP3K3 | 1.91950395 |
| 20 | BUB1 | 1.87099178 |
| 21 | NME2 | 1.84209871 |
| 22 | PKN1 | 1.83600418 |
| 23 | GRK6 | 1.76014533 |
| 24 | FGR | 1.73913960 |
| 25 | JAK3 | 1.68842093 |
| 26 | WNK4 | 1.66657649 |
| 27 | CDK19 | 1.66100628 |
| 28 | SMG1 | 1.65973810 |
| 29 | CSNK1G3 | 1.53923116 |
| 30 | TNK2 | 1.53124312 |
| 31 | TAOK1 | 1.52496829 |
| 32 | BCKDK | 1.46166315 |
| 33 | STK16 | 1.40423539 |
| 34 | MAP4K1 | 1.32578649 |
| 35 | MAP3K1 | 1.29551419 |
| 36 | EIF2AK1 | 1.27494367 |
| 37 | MAP2K2 | 1.27178987 |
| 38 | SCYL2 | 1.25295575 |
| 39 | STK10 | 1.22067043 |
| 40 | CSNK1A1L | 1.20893100 |
| 41 | BMPR2 | 1.20456258 |
| 42 | PIM2 | 1.20385978 |
| 43 | CSK | 1.15749068 |
| 44 | CSF1R | 1.12119991 |
| 45 | TRPM7 | 1.09479865 |
| 46 | TXK | 1.07059979 |
| 47 | CSNK1G1 | 1.06078731 |
| 48 | ROCK2 | 1.04048343 |
| 49 | EIF2AK3 | 1.02778009 |
| 50 | DYRK2 | 1.01867220 |
| 51 | ARAF | 1.01643755 |
| 52 | GRK7 | 1.01608020 |
| 53 | LRRK2 | 1.00335986 |
| 54 | BTK | 0.95580441 |
| 55 | TBK1 | 0.95504203 |
| 56 | STK4 | 0.95161366 |
| 57 | MARK3 | 0.87828831 |
| 58 | KIT | 0.87633771 |
| 59 | ABL2 | 0.85471926 |
| 60 | RPS6KA5 | 0.85457890 |
| 61 | MAP3K8 | 0.84883636 |
| 62 | JAK2 | 0.83858296 |
| 63 | TESK1 | 0.82383585 |
| 64 | TLK1 | 0.82268942 |
| 65 | PAK1 | 0.81930094 |
| 66 | BMX | 0.80804303 |
| 67 | UHMK1 | 0.79927320 |
| 68 | TGFBR2 | 0.78389921 |
| 69 | SIK3 | 0.77833466 |
| 70 | VRK1 | 0.75873212 |
| 71 | ITK | 0.74983823 |
| 72 | DAPK1 | 0.74060317 |
| 73 | TEC | 0.73340005 |
| 74 | CSNK1G2 | 0.72102817 |
| 75 | CAMK2B | 0.71828725 |
| 76 | PIM1 | 0.69046662 |
| 77 | NEK6 | 0.68794182 |
| 78 | CAMK2D | 0.67786006 |
| 79 | WNK1 | 0.66947538 |
| 80 | MAP3K5 | 0.66700595 |
| 81 | IKBKB | 0.65912614 |
| 82 | MAP3K13 | 0.65802792 |
| 83 | PRKCQ | 0.64674889 |
| 84 | LCK | 0.63097014 |
| 85 | TNIK | 0.62739470 |
| 86 | LYN | 0.62678225 |
| 87 | MST1R | 0.59797900 |
| 88 | KDR | 0.59277482 |
| 89 | ERN1 | 0.58053490 |
| 90 | TYK2 | 0.57318784 |
| 91 | TAOK3 | 0.57076908 |
| 92 | PDPK1 | 0.55886302 |
| 93 | ICK | 0.54763738 |
| 94 | ILK | 0.54476385 |
| 95 | FGFR2 | 0.53102838 |
| 96 | WEE1 | 0.51778515 |
| 97 | MAP3K14 | 0.51551882 |
| 98 | PRPF4B | 0.50942578 |
| 99 | MATK | 0.50121832 |
| 100 | PRKG2 | 0.49491808 |
| 101 | MAPKAPK2 | 0.46473581 |
| 102 | RAF1 | 0.45449539 |
| 103 | RPS6KC1 | 0.45405067 |
| 104 | RPS6KL1 | 0.45405067 |
| 105 | IKBKE | 0.44940396 |
| 106 | IRAK2 | 0.44377951 |
| 107 | CDK14 | 0.44152503 |
| 108 | CAMK2G | 0.44113692 |
| 109 | PDK2 | 0.43424960 |
| 110 | PRKCD | 0.42155132 |
| 111 | FES | 0.41944255 |
| 112 | PAK4 | 0.41782637 |
| 113 | ZAP70 | 0.40916624 |
| 114 | SYK | 0.39369433 |
| 115 | FYN | 0.39171421 |
| 116 | CCNB1 | 0.38919005 |
| 117 | NTRK1 | 0.38650080 |
| 118 | PRKD1 | 0.37969793 |
| 119 | GSK3A | 0.37491891 |
| 120 | PRKD2 | 0.37199469 |
| 121 | DAPK3 | 0.36569528 |
| 122 | IRAK3 | 0.36320371 |
| 123 | PDK1 | 0.35530332 |
| 124 | MAPKAPK3 | 0.35237478 |
| 125 | TRIB3 | 0.34156295 |
| 126 | RPS6KA6 | 0.33936025 |
| 127 | AURKA | 0.33052938 |
| 128 | NUAK1 | 0.32753067 |
| 129 | ALK | 0.32554104 |
| 130 | MOS | 0.32257251 |
| 131 | MAP2K6 | 0.32128391 |
| 132 | DYRK3 | 0.31883606 |
| 133 | IRAK1 | 0.31479173 |
| 134 | CDK15 | 0.31226240 |
| 135 | PIK3CG | 0.31110632 |
| 136 | MAP3K12 | 0.30996561 |
| 137 | PTK6 | 0.30778386 |
| 138 | CDK4 | 0.30649954 |
| 139 | HCK | 0.30639114 |
| 140 | CDK11A | 0.30575658 |
| 141 | ABL1 | 0.30323861 |
| 142 | PIK3CA | 0.29188012 |
| 143 | BMPR1B | 0.28484744 |
| 144 | GRK1 | 0.26138077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.63455909 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.34625065 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.02303390 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.81285861 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.50013823 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.46946121 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.45550746 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39244309 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.23278433 |
| 10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.22338463 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.14141235 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96854822 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.93926345 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.93906553 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89762237 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86816659 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.86305977 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.86124419 |
| 19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.81034405 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79764278 |
| 21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.74816454 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.72957210 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.53601921 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53510262 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52816772 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.48984212 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47769252 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44732284 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44351984 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.43549657 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.42156788 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40832204 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39032212 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.35743343 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.35399422 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.34389184 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.32018135 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31814242 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.25854824 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24514330 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20038107 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17980160 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16388623 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.15046047 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14277357 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13802755 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10112068 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08658495 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06597091 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06453083 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06035762 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05476987 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04548481 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 1.01644222 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01106514 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 1.00447002 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99746254 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.97674585 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96781910 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96664925 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96544296 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96276412 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95348278 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94070419 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.94041106 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.93317812 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93084288 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.91419097 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86924030 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85318194 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82714609 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82324687 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79577702 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79259146 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77668975 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.77116956 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76209552 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.75474526 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.75045510 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.72618178 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71384580 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71000207 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70808674 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69645690 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.69417241 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68223163 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66180642 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.65900419 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65516789 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64083999 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63224862 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63105534 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.62874369 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62583956 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.61627538 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60994520 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.60518507 |
| 98 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59913914 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57557197 |
| 100 | Mismatch repair_Homo sapiens_hsa03430 | 0.57134068 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55502162 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55271684 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.52651938 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51352777 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51039858 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50113004 |
| 107 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49479996 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47552883 |
| 109 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47034130 |
| 110 | Allograft rejection_Homo sapiens_hsa05330 | 0.46418267 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46103372 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46098966 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45786880 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45765299 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45738332 |
| 116 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45637675 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45128852 |
| 118 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44635377 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.44548885 |
| 120 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43892309 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43777459 |
| 122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41673051 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41019848 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39105619 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.38664264 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38088062 |
| 127 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.37894065 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37541636 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37103617 |
| 130 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36770244 |
| 131 | Spliceosome_Homo sapiens_hsa03040 | 0.36648847 |
| 132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36378893 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36355996 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35950410 |
| 135 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35893031 |
| 136 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35079779 |
| 137 | * Carbon metabolism_Homo sapiens_hsa01200 | 0.34837059 |
| 138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34762081 |
| 139 | Endocytosis_Homo sapiens_hsa04144 | 0.33787132 |
| 140 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33705729 |
| 141 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33703958 |
| 142 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33516653 |
| 143 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33406328 |
| 144 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32460368 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32104816 |
| 146 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.31849333 |

